Deliver Your News to the World

Cardiac Marker CKMB Isozyme, Troponin and MPO increased production


St. Louis, MO, ( Lee Biosolutions has increased production of native human creatine kinase mb isoenzyme and is supplying in bulk recombinant creatine kinase MB (CKMB) isoenzymes and troponins to the clinical diagnostic market.

Creatine kinase MB isoenzyme is a cardiac marker produced primarily in the heart. Elevated levels of creatine kinase in the bloodstream are indicative of heart damage, probably due to a heart attack. Creatine Kinase MB isoenzyme has also been found effective in determining whether or not clot-dissolving drugs are working. CK-MB isoenzyme levels are one of a number of blood tests typically administered to patients presenting with chest pain.

CKMB,troponin, mpo and c-reactive protein are some of a number of substances found in the blood that are helping researchers predict, diagnose and treat heart attacks better than ever before, Lee Biosolutions President Burton Lee said. Researchers use these materials to advance their understanding of the critical role they play in heart-related illness.

Lee Biosolutions offers creatine kinase MB derived from the human heart, as well as lab created recombinant CKMB. In addition, the company has a variety of creatine kinase based products for other research purposes as well.

Additional products in Lee Biosolutions cardiac market line include myoglobin , C-reactive protein, Myeloperoxidase, Troponin , other Creatine kinase isoenzymes and lipoproteins. Some markers are more conclusive than others, but all are indicative at some level of a heart attack.

Lee Biosolutions is a leader in the cardiac marker industry, providing high quality enzymes and related proteins to clinical labs and researchers around the world, developing tomorrows cures. The company has provided proteins used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the companys


 cardiac marker
 heart attack
 ck mb isoenzyme

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.